Development and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular CarcinomaBinghua Li, Yitao Ding|Scientific Reports|2017Cited by 83
S100A9 promotes resistance to anti-PD-1 immunotherapy in hepatocellular carcinoma by degrading PARP1 and activating the STAT3/PD-L1 pathwayXianwei Zhou, Binghua Li|Cellular Oncology|2025Cited by 3